Scientists track memory in seniors on new cancer drugs
NCT ID NCT07411105
Summary
This study aims to see if it's practical to track memory and concentration in adults aged 65 and older who are starting a new type of cancer treatment called immune checkpoint inhibitors. About 30 participants will take memory tests every six weeks for six months. The main goal is to learn how to best run this type of study and gather early information on how thinking skills might change during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. James's Hospital, Dublin
Dublin, Dublin, D09HP89, Ireland
-
St. Vincent's University Hospital, Dublin
Dublin, Dublin, D09HP89, Ireland
Conditions
Explore the condition pages connected to this study.